Language and content disclaimer
The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.
Linking to Non-Government of Canada Websites
Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.
Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.
View trial details
Overview
Official protocol title:
A PHASE 3 RANDOMIZED, DOUBLE BLIND, MULTI CENTER, LONG TERM EXTENSION STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF 04965842 WITH OR WITHOUT TOPICAL MEDICATIONS, ADMINISTERED TO SUBJECTS AGED 12 YEARS AND OLDER WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Intervention/treatment:
Name given to the drug used in the clinical trial. This may be a code name, a chemical name of the active ingredient, a non-proprietary name or brand name.
ABROCITINIB (PF-04965842)
Medical condition:
The disease or condition that's being studied in the clinical trial.
Protocol code:
An alpha-numeric sequence generated by the sponsor that can vary in length. Used as a reference to help identify a specific clinical trial protocol. Formerly referred to as 'protocol number'.
B7451015
Control number:
A unique 6-digit identification number Health Canada assigns to each clinical trial application.
214555
Status:
The status for the clinical trial as a whole. Note that the status for each site may be different and should always be confirmed with the clinical trial sponsor. Health Canada uses information provided by the sponsor to an international clinical trial registry to determine status values for each clinical trial. Status values on the portal can include:
• Not yet recruiting - Participants are not yet being recruited or enrolled at any site.
• Recruiting - Participants are currently being recruited.
• Active, not recruiting - The clinical trial is ongoing but new participants are not currently being recruited or enrolled.
• On hold - The clinical trial has been temporarily stopped, but it may start again.
• Closed - The clinical trial has either ended normally and participants are no longer being examined or treated, or it has stopped early and will not start again.
• Unknown - The status of the clinical trial has not been verified in the registry in the last 2 years. Please contact the sponsor.
• No match, ongoing - Please contact sponsor for status information.
• Other - Please contact sponsor for status information.
Closed
Approved:
The date that the clinical trial has been determined to meet Health Canada’s regulatory requirements. For drug clinical trials, this means that a no objection letter or an authorization was issued.
April 12, 2018
Trial phase:
The stage of a clinical trial, based on factors such as the objectives of the trial and number of participants. Phase data displayed in the portal is taken from international registry data.
For more information see "Phases of drug trials" on the Definitions webpage
Phase 3
For more information:
ClinicalTrials.gov -
NCT03422822
This is an external link. The information is not authorized by the Government of Canada.
Eligibility
The characteristics people must have or the requirements they must meet to participate in the clinical trial. Eligibility criteria include both inclusion criteria (must have for a person to participate) and exclusion criteria (prevent a person from participating).
Review the exact criteria from the registry or the sponsor before making a decision to participate. The following values may be available on the portal:
Sex: an eligibility criteria based on biological characteristics. Information in the portal is based on available data and will default to 'all' when no other data is available.
Age: The age a person must be to participate in the clinical trial.
Accepts Healthy Volunteers: People who do not have the disease or condition can participate in the clinical trial.
Sex:
ALL
Accepts healthy volunteers:
No
Locations
Alberta
Alberta Dermasurgery Centre
Edmonton, Alberta, T6G 1C3
Beacon Dermatology
Calgary, Alberta, T3E 0B2
CARE Clinic Ltd
Red Deer, Alberta, T4P-1K4
Dermatology Research Institute
Dermatology Research Institute
Stratica Medical
Edmonton, Alberta, T5K 1X3
British Columbia
Dr. Chih-ho Hong Medical Inc
Surrey, British Columbia, V3R 6A7
Pacific Dermaesthetics Inc.
Vancouver, British Columbia, V6H4E1
University of British Columbia Department of Dermatology and Skin Science
Vancouver, British Columbia, V5Z 4E8
Manitoba
Winnipeg Clinic
Winnipeg, Manitoba, R3C 0N2
Wiseman Dermatology Research Inc.
Winnipeg, Manitoba, R3M 3Z4
Newfoundland and Labrador
Karma Clinical Trials, Inc.
St. John's, Newfoundland and Labrador, A1A 4Y3
Ontario
AvantDerm
Toronto, Ontario, M5A 3R6
Centre de Recherche Saint-Louis inc.
Dermatology Ottawa Research Centre
DermEdge Research
Mississauga, Ontario, L4Y 4C5
K.Papp Clinical Research Inc.
Waterloo, Ontario, N2J 1C4
Kingsway Clinical Research
Etobicoke, Ontario, M8X 1Y9
Lynderm Research Inc.
Markham, Ontario, L3P 1X2
Manna Research Inc.(Toronto)
Toronto, Ontario, M9W 4L6
Medicor Research Inc
Greater Sudbury, Ontario, P3C 1X3
North Bay Dermatology Centre
North Bay, Ontario, P1B 3Z7
Oshawa Clinic Dermatology Trials
Research Toronto
Toronto, Ontario, M4W 2N4
SimcoDerm Medical and Surgical Dermatology Center
SKiN Centre for Dermatology
Peterborough, Ontario, K9J 5K2
Sudbury Skin Clinique
Greater Sudbury, Ontario, P3C 1X8
The Centre for Clinical Trials
Oakville, Ontario, L6J 7W5
The Centre for Dermatology
Richmond Hill, Ontario, L4B 1A5
XLR8 Medical Research Inc.
Windsor, Ontario, N8T 1E6
York Dermatology Clinic and Research Centre
Richmond Hill, Ontario, L4C 9M7
Quebec
Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ)
Clinique de Radiologie du Saguenay Enr.
Chicoutimi, Quebec, G7H 6B9
Diex Research Sherbrooke Inc.
Sherbrooke, Quebec, J1L 0H8
Innovaderm Research Inc.
Montreal, Quebec, H2X 2V1
Intermed groupe santé
Chicoutimi, Quebec, G7H 7Y8
Saskatchewan
Dr. Rachel Asiniwasis, Medical Professional Corp.
Regina, Saskatchewan, S4V1R9